Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2022-04-01
سلاسل:CJC Open
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2589790X21003565

مواد مشابهة

مواد مشابهة